CAR T-Cell Therapy: What It’s Like to Get This Groundbreaking New Cancer Treatment

Fact Checked

SurvivorNet Fact Checking and Medical Review Standards:  

The SurvivorNet News Team creates high quality medical information that complies with our industry leading standards for factual accuracy and sourcing from leading experts at academic medical institutions. Every news article is thoroughly fact-checked by our physician collaborators. We vet each piece of work for factual integrity, impartiality, and clearly label any professional conflicts.

All SurvivorNet articles adhere to the following standards:

  1. All studies and research papers cited are from reputable academic medical institutions or peer-reviewed journals.
  2. When we use data, statistics, or quotes these references link to the original source.
  3. All content related to new treatments, drugs, procedures, and so on must clearly describe availability, side effects, treatment target (such as triple negative breast cancer)
  4. All medical information on SurvivorNet is sourced from respected medical professionals with verified medical credentials and links are provided to these sources.
  5. We strive to give the reader relevant background information and include, clearly-sourced contextual health information in all articles. Readers are clearly alerted to any conflicts of interest from a medical source or the authors of a cited study.
/ Updated April 8th, 2022

CAR T-Cell Therapy: What It’s Like to Get This Groundbreaking New Cancer Treatment

NOW
PLAYING
New Therapy Provides Hope for More Patients With Large B-Cell Lymphoma
NOW
PLAYING
One Patient’s Success Story Using Newly Approved CAR-T Cell Therapy to Treat Acute Lymphoblastic Leukemia in Adult Patients
NOW
PLAYING
The Remarkable Story of Pharma CEO Christi Shaw Who Took a Year Off to Care For Her Sister With Blood Cancer, and Then Helped Launch a Breakthrough CAR-T Cell Therapy
NOW
PLAYING
CAR T-Cell Therapy Side Effects Can Be Serious, But Many Are Short-Lived
NOW
PLAYING
Why CAR T-Cell Therapy Is So Exciting

Recurrence: Options After Diffuse Large B-Cell Lymphoma Recurrence

SEE MORE   

  • There are several treatment options available if non-Hodgkin lymphoma returns
  • The most common first treatment after relapse is another round of chemotherapy
  • For patients whose cancer does not respond well to chemo, doctors may explore immune-therapies such as CAR-T therapy

Recurrence: Options After Diffuse Large B-Cell Lymphoma Recurrence

  • There are several treatment options available if non-Hodgkin lymphoma returns
  • The most common first treatment after relapse is another round of chemotherapy
  • For patients whose cancer does not respond well to chemo, doctors may explore immune-therapies such as CAR-T therapy
×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.